FDA Warns Against Illegal Online Sales of Unapproved Botox Products
Consumers are urged to exercise extreme caution when seeking cosmetic injectables, as the FDA cracks down on websites peddling potentially hazardous, unapproved botulinum toxin products.
The U.S. Food and Drug Management issued warnings on November 5, 2025, to the owners of 18 websites illegally marketing unapproved and misbranded botulinum toxin products – commonly known as Botox. The agency has received reports of adverse events, including symptoms of botulism, linked to these products, raising serious public health concerns.
Botulinum toxin products are powerful injectable drugs that temporarily reduce muscle movement by blocking nerve activity. While approved for cosmetic uses like wrinkle reduction,they also treat medical conditions such as chronic migraines and muscle stiffness. Though, the FDA emphasizes that unapproved versions pose significant risks.
“Unapproved and misbranded Botox products carry serious health risks,” stated FDA Commissioner Marty Makary, M.D., M.P.H. “Today we’re taking action to protect American consumers and prevent online entities from selling these dangerous products.”
FDA-approved botulinum toxin products carry a “boxed warning” – the agency’s most serious type of warning – highlighting the potential for severe or life-threatening side effects. This warning specifically notes the risk of botulism, a potentially fatal illness that attacks the nervous system, causing muscle weakness, difficulty breathing, and even death.
The FDA stresses that legitimate botulinum toxin products, such as botox, require a prescription from a licensed healthcare professional. Patients should only receive these injections from qualified and trained providers using products sourced from authorized distributors. Purchasing from unauthorized sources increases the risk of receiving a product that is unapproved, misbranded, counterfeit, contaminated, improperly stored, or simply ineffective.
Individuals experiencing symptoms of botulism – including difficulty swallowing or breathing – after receiving a botulinum toxin injection are urged to seek immediate medical attention.
The FDA issued warning letters to the following websites:
- acecosm.com
- aesthetic-essentials.com
- celestapro.com
- cosmenic.net
- cosmo-korea.com
- derma-solution.com
- dermaxshop.com
- ellepharm.com
- estaderma.com
- filleroutlet.com
- glamderma.com
- glowface.store
- glownestbeauty.com
- koreafillerexperts.com
- koreanfillers.com
- maypharm.net
- meamoshop.com
- mjsmedicals.com
Healthcare professionals and consumers are encouraged to report any adverse events related to these products to the FDA’s MedWatch Safety Details and Adverse Event Reporting Program.
The FDA, operating under the U.S. Department of Health and Human Services, is dedicated to safeguarding public health by ensuring the safety, effectiveness, and security of a wide range of products, including drugs, vaccines, medical devices, food, cosmetics, and tobacco. This latest action underscores the agency’s commitment to protecting consumers from the dangers of unregulated and potentially harmful products.
– Botulism symptoms can include muscle weakness and difficulty breathing. Seek immediate medical attention if you experience these after an injection.
– Always verify your provider is licensed and uses FDA-approved products from authorized distributors.
– Can Botox be used for more than wrinkles? – Yes, it treats conditions like chronic migraines and muscle stiffness.
